|
Tabla 1: Sintomatología asociada a COVID-19. Table 1: Symptomatology associated with COVID-19. |
||||||||||||||||
|
|
Salinas Aguirre et al13 |
Casas Rojo et al14 |
Stawicki SP et al15 |
Bonet Beltrán M et al16 |
Huang C et al17 |
Xu et al18 |
Liu et al19 |
Wang et al20 |
Wei XS et al21 |
Lechien JR et al22 |
Lai X et al23 |
Lapostolle F et al24 |
Chen Y et al25 |
O’Reilly et al26 |
Gaur et al27 |
Aggarwal et al28 |
|
Síntomas claros más frecuentes ≥ 40% |
% |
% |
% |
% |
% |
% |
% |
% |
% |
% |
% |
% |
% |
% |
% |
% |
|
Fiebre 38o C |
58.4 |
85.2 |
83-98.6 |
17.8 |
|
77 |
76.67 |
81.25 |
86 |
|
60.9 |
92.5 |
65.78 |
|
65.78 |
68 |
|
Febrícula |
|
|
|
43.6 |
98 |
|
|
|
|
|
|
|
|
|
|
|
|
Tos seca |
69.5 |
76.5 |
46-82 |
57.4 |
76 |
81 |
83.33 |
58.75 |
71 |
|
|
94 |
42.10 |
|
42.3 |
84.4 |
|
Falta de aire (disnea) |
23 |
57.6 |
19-31.2 |
8.9 |
55 |
3 |
46.67 |
|
|
|
|
|
60.52 |
77 |
23.7 |
90 |
|
Dolor muscular (mialgias) |
46 |
|
11-44 |
|
44 |
52 |
70 |
23.75 |
100 |
62.5 |
45.5 |
57 |
15.79 |
67 |
38.46 |
43.75 |
|
Dolor de cabeza |
75.2 |
|
6.5-12.1 |
37.6 |
8 |
34 |
53.33 |
|
|
70.3 |
|
55 |
|
|
|
|
|
Fatiga |
|
47.5 |
11-69.6 |
|
|
|
|
35 |
|
|
|
|
|
100 |
|
|
|
Anorexia |
|
22.4 |
39.9-50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Síntomas asociados medianamente frecuentes |
||||||||||||||||
|
Dolor articular |
36.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malestar general |
32.5 |
|
|
59.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Dolor de garganta (odinofagia) |
30.6 |
|
5-17.4 |
18.8 |
|
|
|
|
|
|
50 |
|
|
|
53.84 |
|
|
Dolor u opresión en el pecho |
17 |
|
2 |
|
|
|
|
|
|
|
|
21 |
26.31 |
|
|
|
|
Escalofríos |
|
|
11 |
|
|
|
|
18.75 |
|
|
|
|
|
|
|
|
|
Diarrea |
|
22.5 |
2-15 |
8.9 |
3 |
8 |
|
|
|
|
|
|
|
67 |
|
|
|
Anosmia y ageusia |
9.1 |
6.3 |
|
6.9 |
|
|
|
|
|
70.2 |
56.4 |
28 |
|
|
|
|
|
Síntomas variables menos frecuentes |
||||||||||||||||
|
Tos con producción de expectoración |
|
|
12-28.2 |
|
28 |
56 |
|
23.75 |
|
|
|
|
|
|
|
|
|
Rinorrea |
16.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Náuseas y vómito |
5.3 |
|
1-10.1 |
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Congestión nasal |
|
|
|
6.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Dolor abdominal |
7.4 |
|
2.2 |
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Hemoptisis (esputo sanguinolento) |
|
|
1-5 |
|
5 |
3 |
|
|
|
|
|
3 |
|
|
|
|
|
Ojos llorosos, rojos o conjuntivitis |
5 |
|
< 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mareo |
|
|
9.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Confusión |
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cianosis |
1.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rash cutáneo |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Contacto con casos positivos a COVID-19 confirmados: 31% según Mancilla-Galindo J et al.29 |
||||||||||||||||